Skip to main content
GRI
NASDAQ Life Sciences

FDA Grants Orphan Drug Status to GRI Bio's IPF Drug GRI-0621, Offering 7 Years Exclusivity

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$2.23
Mkt Cap
$4.108M
52W Low
$1.97
52W High
$80.36
52W Position info
13% above low
Off High info
97% below high
Rel. Volume info
7.0× avg
Market data snapshot near publication time

GRI is trading near its 52-week low of $1.97 (13% above the low) on elevated volume (7.0× avg).

Summary

GRI Bio secured FDA Orphan Drug Designation for its lead candidate, GRI-0621, for Idiopathic Pulmonary Fibrosis. This follows positive Phase 2a clinical data for the drug announced on May 14th. The designation is a significant regulatory milestone, offering potential for seven years of U.S. market exclusivity upon approval, along with tax credits and fee waivers. This development is crucial for the micro-cap company, especially given its recent Q1 2026 report which included a going concern warning and substantial dilution.

At the time of this announcement, GRI was trading at $2.23 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.1M. The 52-week trading range was $1.97 to $80.36. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

GRI - Latest Insights

GRI
Sep 28, 2026, 4:43 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $2.07
Real-time Price: $1.83 info
Change: -$0.240 (-12%) info
Market Cap: $4.11M info
GRI
Sep 08, 2026, 8:16 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.60
Real-time Price: $1.83 info
Change: -$0.770 (-30%) info
Market Cap: $4.11M info
GRI
Aug 24, 2026, 9:05 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.70
Real-time Price: $1.83 info
Change: +$0.1281 (+8%) info
Market Cap: $4.11M info
GRI
Aug 14, 2026, 7:44 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.88
Real-time Price: $1.83 info
Change: -$0.050 (-3%) info
Market Cap: $4.11M info
GRI
Jun 18, 2026, 4:50 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.90
Real-time Price: $1.83 info
Change: -$0.0695 (-4%) info
Market Cap: $4.11M info